Zydus launches Ujvira (trastuzumab emtansine) for breast cancer treatment
The drug is being offered at Rs 32495 for a 100 mg vial
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
COVID-19 trials and tribulations for treatments
Dr Arun Bhatt, Consultant – Clinical Research & Drug Development states that in the absence of a peer-reviewed publication in…
COVID-19 vaccines ‘highly effective’ against B1.617.2 variant: UK research
PHE said that while the Pfizer/BioNTech vaccine was 88 per cent effective against symptomatic COVID-19 from the B1.617.2 variant…
Paediatric trials of Covaxin are likely to start from June 1: Dr Raches Ella
Bharat Biotech is ramping up its manufacturing capacity to 700 million doses which are likely to be achieved by the end of this…
Moderna, Samsung Biologics sign agreement for fill-finish manufacturing of COVID-19 vaccine
The agreement will further enable global supply of mRNA-1273, Moderna’s COVID-19 vaccine with Samsung Biologics’ fill and finish…
India, Pfizer discuss vaccine deal, seek to resolve dissension over vaccine indemnity: Report
India has not given any manufacturer of a COVID-19 vaccine indemnity against the costs of compensation for any severe side…
MSN Laboratories launches Posaconazole to treat mucormycosis
MSN has launched the product under the brand name PosaOne as 100 mg Delayed-Release tablets and 300 mg injections, respectively
Natco Pharma gets USFDA approval for lenalidomide capsules
They are used to treat various types of cancers
COVID-19 to have long-term impact on global diabetes market: GlobalData
As diabetes case numbers are expected to be further fuelled by COVID-19, and as the pathophysiology of COVID-19 induced diabetes…
Sun Pharma recalls 50,868 bottles of Metformin HCL ER tablets in US
The tablets were produced at the company's Halol (Gujarat) based manufacturing plant and later distributed in the US by Cranbury…